Professor of Medicine
Hematology
Dr. Francesco Turturro, MD
|
|
Give Review
Francesco Turturro is an expert in the field of Hematology. He researched medicine at University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63 in research and 72 in primary care medicine Francesco Turturro is a published doctor. He has 53 publications published. The most current publication "Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease." Francesco Turturro accepts all Medicare patients.
Publications
- Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- Prevalence and association of hepatitis C virus infection with different types of Lymphoma.
- The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremia.
- Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease.
- A clinician's guide to double hit Lymphomas.
- Safety and activity of lenalidomide and rituximab in untreated indolent Lymphoma: an open-label, phase 2 trial.
- BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic Leukemia/lymphoma: reduced myelosuppression and GVHD.
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Ocular adnexal lymphoma: validation of American Joint Committee on Cancer seventh edition staging guidelines.
- Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.
- Mechanistic studies on the synergistic cytotoxicity of the nucleoside Analogs gemcitabine and clofarabine in multiple myeloma: Relevance of p53 and its clinical implic...
- Oligosecretory biclonal multiple myeloma.
- Biochemical differences between SUDHL-1 and KARPAS 299 Cells derived from t(2;5)-positive anaplastic large Cell lymphoma are responsible for the different sensitivity ...
- Comparison of the effects of recombinant adenovirus-mediated expression of wild-type p53 and p27Kip1 on Cell cycle and apoptosis in SUDHL-1 Cells derived from anaplast...
- Adenovirus-p53-mediated gene therapy of anaplastic large Cell lymphoma with t(2;5) in a nude mouse model.
- In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cel...
- Adenoviral vectors efficiently target Cell lines derived from selected lymphocytic malignancies, including anaplastic large Cell lymphoma and Hodgkin's disease.
- Ring appearance of Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small Cell carcinoma.
- Extrahepatic manifestations of hepatitis of C virus infection.
- Apolipoprotein C-II deficiency: detection of immunoreactive apolipoprotein C-II in the intestinal mucosa of two patients.
- A complex Hind III polymorphism in the human apolipoprotein-B gene (APOB).
- Apo C-II deficiency type Bari.
- Recombinant adenovirus-mediated cytotoxic gene therapy of lymphoproliferative Disorders: is CAR important for the vector to ride?
- Anaplastic lymphoma kinase proteins in growth control and Cancer.
- The emerging normal and disease-related roles of anaplastic Lymphoma kinase.
- Thioredoxin-interacting protein and chronic lymphocytic Leukemia.
- BCR/ABL, mRNA translation and apoptosis.
- Troglitazone''s rapid and sustained activation of ERK1/2 induces Cellular acidosis in LLC-PK1-F+ Cells: physiological responses.
- Response to dexamethasone is glucose-sensitive in multiple myeloma Cell lines.
- Wnt/?-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast Cancer-derived cells MDA-MB-231.
- Troglitazone regulates anaplerosis via a pull/push affect on glutamate dehydrogenase mediated glutamate deamination in kidney-derived epithelial Cells; implications fo...
- Glutaminolysis and glycolysis regulation by troglitazone in breast Cancer cells: Relationship to mitochondrial membrane potential.
- Caution using hypomethylating agents in myelodysplasia or myeloid Leukemia with complex cytogenetics.
- Beyond the Knudson''s hypothesis in von Hippel-Lindau (VHL) Disease-proposing vitronectin as a "gene modifier".
- Troglitazone induced cytosolic acidification via extraCellular signal-response kinase activation and mitochondrial depolarization: complex I proton pumping regulates a...
- Re: Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusion for Duchenne muscular dystrophy scoliosis...
- Role of epidermal growth factor receptor (EGFR)-signaling versus Cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of brea...
- Update on front-line therapy for follicular Lymphoma: chemo-immunotherapy with rituximab and survival.
- Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast Cancer-derived cells and regulates paclitaxel IC50.
- Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast Cancer-derived cells MDA-MB-231.
- ALK-mediated Na+/H+ exchanger-dependent intraCellular alkalinization: does it matter for oncogenesis?
- Phase II trial of denileukin diftitox for relapsed/refractory T-Cell non-Hodgkin lymphoma.
- Denileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived Disorders.
- Targeting the Na(+)/H(+) exchanger: an old concept with new perspectives in the treatment of hematological malignancies.
- Troglitazone and pioglitazone interactions via PPAR-gamma-independent and -dependent pathways in regulating physiological responses in renal tubule-derived Cell lines.
- Impaired primary hemostasis with normal platelet function in Duchenne muscular dystrophy during highly-invasive spinal surgery.
- Plasma Coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral antiCoagulation therapy.
- Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast Cancer-derived cell lines.
- TroglitaZone acts by PPARgamma and PPARgamma-independent pathways on LLC-PK1-F+ acid-base metabolism.
- Prolonged adenovirus-mediated expression of p27(Kip1) unveils unexpected effects of this protein on the phenotype of SUDHL-1 Cells derived from t(2;5)-anaplastic large...
- Recombinant adenovirus-mediated cytotoxic gene therapy and lymphoproliferative disorders: Analysis based on pharmacodynamics.
- Model of inhibition of the NPM-ALK kinase activity by herbimycin A.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Kentucky College of Medicine -
University of Bari Faculty of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1649297409 | |
| NPPES Provider LastName | TURTURRO | |
| NPPES Provider FirstName | FRANCESCO | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 467.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 3.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649297409 |
| Last Name Of The Provider | TURTURRO |
| First Name Of The Provider | FRANCESCO |
| View All |
Similar Doctors
|
|
Dr. Agop Y. Bedikian, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sattva S. Neelapu, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kenneth K. Wu, MD |
|
|
Dr. Nishin A. Bhadkamkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debasish P. Tripathy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caroline C. Waddell, MD |
|
|
Dr. Shahab A. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Hwu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naoto Ueno, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|